Appointments at PharmaNet, Chiltern and Cardinal Health – People on the move
PharmaNet has appointed Stephen Kasay as its chief information officer. Kasay will take responsibility for global corporate information technology, including strategy development and execution. He has more than 20 years experience in pharma IT.
Sharon Moore has been appointed as executive vice president (VP), global quality and medical affairs at Chiltern. Moore has 15 years experience, joining US-based contract research organisation (CRO) CTMS in 1998. CTMS was acquired by Chiltern in 2007.
Cardinal Health has elected Carrie Cox to its board of directors. Most recently Cox worked at Schering-Plough, leaving the big pharma at the close of its merger with Merck & Co, and she has also served as president of Pharmacia’s global pharmaceutical business.
Gerard Rabbette has been appointed as CEO of UniPhar. Rabbette has previously worked as managing director of pharma logistics services business Movianto and head of Celesio Solutions.
Eucodis Bioscience has promoted Thomas Fischer from chief financial officer to CEO. Rudy Pandjaitan, former CEO of Eucodis, has led a management buy-in of the company’s French research subsidiary.
Andrew Last has joined Affymetrix as chief commercial officer. Last has more than 25 years experience in the life science, pharmaceutical, diagnostics and agrochemical industries at companies including Incyte Genomics, Applied Biosystems, Becton Dickinson and Monsanto.
Aptilon, a provider of on-line marketing services targeting physicians, has appointed Robert Steinfeld to the business’ board of directors. Steinfeld spent nine years at IMS Health and has also held positions at Cognizant and Ultramar.
